Vania Manolova

3.2k total citations · 2 hit papers
33 papers, 2.2k citations indexed

About

Vania Manolova is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Vania Manolova has authored 33 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 14 papers in Immunology and 12 papers in Genetics. Recurrent topics in Vania Manolova's work include Iron Metabolism and Disorders (12 papers), Hemoglobinopathies and Related Disorders (12 papers) and Immune Cell Function and Interaction (11 papers). Vania Manolova is often cited by papers focused on Iron Metabolism and Disorders (12 papers), Hemoglobinopathies and Related Disorders (12 papers) and Immune Cell Function and Interaction (11 papers). Vania Manolova collaborates with scholars based in Switzerland, United States and United Kingdom. Vania Manolova's co-authors include Martin F. Bachmann, Katrin Schwarz, Philippe Saudan, Monika Bauer, Anna Flace, Anne‐Cathrine S. Vogt, Tasneem Arsiwala, Mona O. Mohsen, Monique Vogel and Tazio Storni and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Vania Manolova

32 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanoparticles target distinct dendritic cell populations according to their size

2008 1.0k citations Vania Manolova, Anna Flace et al. European Journal of Immunology profile →
On Iron Metabolism and Its Regulation

2021 291 citations Anne‐Cathrine S. Vogt, Tasneem Arsiwala et al. International Journal of Molecular Sciences profile →

Peers

Countries citing papers authored by Vania Manolova

Since Specialization

Citations

This map shows the geographic impact of Vania Manolova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vania Manolova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vania Manolova more than expected).

Fields of papers citing papers by Vania Manolova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vania Manolova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vania Manolova. The network helps show where Vania Manolova may publish in the future.

Co-authorship network of co-authors of Vania Manolova

This figure shows the co-authorship network connecting the top 25 collaborators of Vania Manolova. A scholar is included among the top collaborators of Vania Manolova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vania Manolova. Vania Manolova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vamifeport, a clinical stage oral ferroportin inhibitor, alleviates murine lupus nephritis: A pilot study 2026 ·Clinical Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Vania Manolova, Yogesh Scindia	0
2	The oral ferroportin inhibitor vamifeport prevents liver iron overload in a mouse model of hemochromatosis 2024 ·HemaSphere ·(unknown), Anna Flace, (unknown), (unknown), (unknown), (unknown), Franz Dürrenberger, Vania Manolova	2
3	Genetic iron overload aggravates, and pharmacological iron restriction improves, MDS pathophysiology in a preclinical study 2024 ·Blood ·(unknown), (unknown), (unknown), Sara Passos, Michela Asperti, (unknown), (unknown), Vania Manolova, Francesca Vinchi	2
4	Combination Therapy with Luspatercept and the Ferroportin Inhibitor Vamifeport Is Superior to Either Drug Alone in Improving Anemia and Reducing Myeloid Skewing in MDS 2023 ·Blood ·(unknown), (unknown), Franz Dürrenberger, Vania Manolova, Francesca Vinchi	1
5	Structures of ferroportin in complex with its specific inhibitor vamifeport 2023 ·eLife ·(unknown), (unknown), (unknown), (unknown), (unknown), Vania Manolova, (unknown), Franz Dürrenberger, Raimund Dutzler, Cristina Manatschal	14
6	Ferroportin inhibitor vamifeport ameliorates ineffective erythropoiesis in a mouse model of β-thalassemia with blood transfusions 2023 ·Haematologica ·(unknown), Anna Flace, (unknown), Giada Ingoglia, (unknown), (unknown), Franz Dürrenberger, Vania Manolova	5
7	Kupffer Cells and Blood Monocytes Orchestrate the Clearance of Iron–Carbohydrate Nanoparticles from Serum 2022 ·International Journal of Molecular Sciences ·Tasneem Arsiwala, Anne‐Cathrine S. Vogt, (unknown), Vania Manolova, Felix Funk, Beat Flühmann, Martin F. Bachmann	10
8	Functional characterization of SLC39 family members ZIP5 and ZIP10 in overexpressing HEK293 cells reveals selective copper transport activity 2022 ·BioMetals ·Marcello Polesel, Álvaro Inglés‐Prieto, (unknown), Evandro Ferrada, (unknown), (unknown), (unknown), (unknown), (unknown), Maria Wilhelm, Vania Manolova	9
9	The Oral Ferroportin Inhibitor VIT-2763 Improves Erythropoiesis without Interfering with Iron Chelation Therapy in a Mouse Model of β-Thalassemia 2021 ·International Journal of Molecular Sciences ·(unknown), Anna Flace, (unknown), Franz Dürrenberger, Vania Manolova	19
10	Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia 2019 ·Journal of Clinical Investigation ·Vania Manolova, (unknown), Anna Flace, (unknown), (unknown), (unknown), (unknown), Franz Dürrenberger	68
11	Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines 2017 ·Frontiers in Immunology ·Ariane C. Gomes, Anna Flace, Philippe Saudan, Franziska Zabel, Gustavo Cabral‐Miranda, Aadil El-Turabi, Vania Manolova, Martin F. Bachmann	37
12	Mechanisms of allergen-specific desensitization 2010 ·Journal of Allergy and Clinical Immunology ·(unknown), Roger R. Beerli, Monika Bauer, Vania Manolova, Klaus Dietmeier, Regula B. Buser, Thomas M. Kündig, Philippe Saudan, Martin F. Bachmann	82
13	Innate signaling regulates cross‐priming at the level of DC licensing and not antigen presentation 2009 ·European Journal of Immunology ·(unknown), Katrin Schwarz, Vania Manolova, (unknown), (unknown), Monika Bauer, Simone Muntwiler, Philippe Saudan, Martin F. Bachmann	28
14	Antigen kinetics determines immune reactivity 2008 ·Proceedings of the National Academy of Sciences ·Pål Johansen, Tazio Storni, Lorna Rettig, Zhiyong Qiu, (unknown), Kevin M. Smith, Vania Manolova, Karl S. Lang, Gabriela Senti, Beat Müllhaupt, Tilman Gerlach, Roberto F. Speck, Adrian Bot, Thomas M. Kündig	149
15	Functional CD1a is stabilized by exogenous lipids 2006 ·European Journal of Immunology ·Vania Manolova, Magdalena Kistowska, Samantha Paoletti, (unknown), Huguette Bausinger, Daniel Hanau, Lucia Mori, Gennaro De Libero	53
16	Cutting Edge: Distinct Roles for T Help and CD40/CD40 Ligand in Regulating Differentiation of Proliferation-Competent Memory CD8+ T Cells 2004 ·The Journal of Immunology ·Martin F. Bachmann, Katrin Schwarz, Petra Wolint, E. Meijerink, Stephen W. Martin, Vania Manolova, Annette Oxenius	44
17	Virus-Like Particles as Carriers for T-Cell Epitopes: Limited Inhibition of T-Cell Priming by Carrier-Specific Antibodies 2004 ·Journal of Virology ·Christiane Ruedl, Katrin Schwarz, Andrea Jegerlehner, Tazio Storni, Vania Manolova, Martin F. Bachmann	49
18	Role of Toll‐like receptors in costimulating cytotoxic T cell responses 2003 ·European Journal of Immunology ·Katrin Schwarz, Tazio Storni, Vania Manolova, Arnaud M. Didierlaurent, Jean‐Claude Sirard, (unknown), Martin F. Bachmann	134
19	CD1a and CD1b surface expression is independent from de novo synthesized glycosphingolipids 2002 ·European Journal of Immunology ·Vania Manolova, Yoshio Hirabayashi, Lucia Mori, Gennaro De Libero	7
20	Cross-Reacting Idiotypes on Anti-insulin Autoantibodies in Autoimmune Diseases, Identified by Monoclonal Antibodies 1998 ·Clinical Immunology and Immunopathology ·(unknown), Maria Stamenova, Vania Manolova, Ivan Kehayov, Lilia Dakovska, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact